Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
Brenda Martínez-González, … , Esteban Domingo, Celia Perales
Brenda Martínez-González, … , Esteban Domingo, Celia Perales
Published March 8, 2022
Citation Information: J Clin Invest. 2022;132(9):e157700. https://doi.org/10.1172/JCI157700.
View: Text | PDF
Concise Communication Virology Article has an altmetric score of 365

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron

  • Text
  • PDF
Abstract

Replication of SARS-CoV-2 in the human population is defined by distributions of mutants that are present at different frequencies within the infected host and can be detected by ultra-deep sequencing techniques. In this study, we examined the SARS-CoV-2 mutant spectra of amplicons from the spike-coding (S-coding) region of 5 nasopharyngeal isolates derived from patients with vaccine breakthrough. Interestingly, all patients became infected with the Alpha variant, but amino acid substitutions that correspond to the Delta Plus, Iota, and Omicron variants were present in the mutant spectra of the resident virus. Deep sequencing analysis of SARS-CoV-2 from patients with vaccine breakthrough revealed a rich reservoir of mutant types and may also identify tolerated substitutions that can be represented in epidemiologically dominant variants.

Authors

Brenda Martínez-González, Lucía Vázquez-Sirvent, María E. Soria, Pablo Mínguez, Llanos Salar-Vidal, Carlos García-Crespo, Isabel Gallego, Ana I. de Ávila, Carlos Llorens, Beatriz Soriano, Ricardo Ramos-Ruiz, Jaime Esteban, Ricardo Fernandez-Roblas, Ignacio Gadea, Carmen Ayuso, Javier Ruíz-Hornillos, Concepción Pérez-Jorge, Esteban Domingo, Celia Perales

×

Total citations by year

Year: 2025 2024 2023 2022 Total
Citations: 2 4 3 4 13
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (13)

Title and authors Publication Year
A general and biomedical perspective of viral quasispecies
Domingo E, Martínez-González B, Somovilla P, García-Crespo C, Soria ME, de Ávila AI, Gadea I, Perales C
RNA 2025
SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.
de Ávila AI, Soria ME, Martínez-González B, Somovilla P, Mínguez P, Salar-Vidal L, Esteban-Muñoz M, Martín-García M, Zuñiga S, Sola I, Enjuanes L, Gadea I, Perales C, Domingo E
Journal of virology 2025
Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.
Delgado S, Somovilla P, Ferrer-Orta C, Martínez-González B, Vázquez-Monteagudo S, Muñoz-Flores J, Soria ME, García-Crespo C, de Ávila AI, Durán-Pastor A, Gadea I, López-Galíndez C, Moran F, Lorenzo-Redondo R, Verdaguer N, Perales C, Domingo E
Proceedings of the National Academy of Sciences 2024
SARS-CoV-2 mutant spectra as variant of concern nurseries: endless variation?
Martínez-González B, Soria ME, Mínguez P, Lorenzo-Redondo R, Salar-Vidal L, López-García A, Esteban-Muñoz M, Durán-Pastor A, Somovilla P, García-Crespo C, de Ávila AI, Gómez J, Esteban J, Fernández-Roblas R, Gadea I, Domingo E, Perales C
Frontiers in microbiology 2024
Point mutations at specific sites of the nsp12–nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2
Ferrer-Orta C, Vázquez-Monteagudo S, Ferrero DS, Martínez-González B, Perales C, Domingo E, Verdaguer N
Proceedings of the National Academy of Sciences 2024
Quasispecies theory and emerging viruses: challenges and applications
Sardanyés J, Perales C, Domingo E, Elena SF
npj Viruses 2024
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin
Somovilla P, García-Crespo C, Martínez-González B, Soria ME, de Ávila AI, Gallego I, Mínguez P, Durán-Pastor A, Ferrer-Orta C, Salar-Vidal L, Esteban-Muñoz M, Zuñiga S, Sola I, Enjuanes L, Esteban J, Fernandez-Roblas R, Gadea I, Gómez J, Verdaguer N, Domingo E, Perales C
Antimicrobial agents and chemotherapy 2023
SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.
Naveca FG, Nascimento VA, Nascimento F, Ogrzewalska M, Pauvolid-Corrêa A, Araújo MF, Arantes I, Batista ÉR, Magalhães AÁ, Vinhal F, Mattos TP, Riediger I, Debur MDC, Grinsztejn B, Veloso VG, Brasil P, Rodrigues RR, Rovaris DB, Fernandes SB, Fernandes C, Santos JHA, Abdalla LF, Costa-Filho R, Silva M, Souza V, Costa ÁA, Mejía M, Brandão MJ, Gonçalves LF, Silva GA, de Jesus MS, Pessoa K, Corado ALG, Duarte DCG, Machado AB, Zukeram KA, Valente N, Lopes RS, Pereira EC, Appolinario LR, Rocha AS, Tort LFL, Sekizuka T, Itokawa K, Hashino M, Kuroda M, Dezordi FZ, Wallau GL, Delatorre E, Gräf T, Siqueira MM, Bello G, Resende PC
Scientific Reports 2023
Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies
Domingo E, Martínez-González B, García-Crespo C, Somovilla P, de Ávila AI, Soria ME, Durán-Pastor A, Perales C
Journal of virology 2023
Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19
S Yang, L Chen, Y Tong, W Yu
Acta pharmaceutica Sinica. B 2022
SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations
Martínez-González B, Soria ME, Vázquez-Sirvent L, Ferrer-Orta C, Lobo-Vega R, Mínguez P, de la Fuente L, Llorens C, Soriano B, Ramos-Ruíz R, Cortón M, López-Rodríguez R, García-Crespo C, Somovilla P, Durán-Pastor A, Gallego I, de Ávila AI, Delgado S, Morán F, López-Galíndez C, Gómez J, Enjuanes L, Salar-Vidal L, Esteban-Muñoz M, Esteban J, Fernández-Roblas R, Gadea I, Ayuso C, Ruíz-Hornillos J, Verdaguer N, Domingo E, Perales C
Pathogens 2022
SARS-CoV-2 Amino Acid Mutations Detection in Greek Patients Infected in the First Wave of the Pandemic
Vassilaki N, Papadimitriou K, Ioannidis A, Papandreou NC, Milona RS, Iconomidou VA, Chatzipanagiotou S
Microorganisms 2022
Assessing the hidden diversity underlying consensus sequences of SARS-CoV-2 using VICOS, a novel bioinformatic pipeline for identification of mixed viral populations.
Goya S, Sosa E, NabaesJodar M, Torres C, König G, Acuña D, Ceballos S, Distéfano AJ, Dopazo H, Dus Santos M, Fass M, Fernández Do Porto D, Fernández A, Gallego F, Gismondi MI, Gramundi I, Lusso S, Martí M, Mazzeo M, Mistchenko AS, Muñoz Hidalgo Marianne G, Natale M, Nardi C, Ousset J, Peralta AV, Pintos C, Puebla AF, Pianciola L, Rivarola M, Turjanski A, Valinotto L, Vera PA, Zaiat J, Zubrycki J, Aulicino P, Viegas M
Virus Research 2022

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 48 news outlets
Blogged by 1
Posted by 5 X users
24 readers on Mendeley
See more details